Behind the Data with Dr. Emily Hollister
In a new series profiling our team of microbiome experts, we have set out to understand microbiome research by asking our bioinformaticians – who have published highly cited papers ranging from topics on paleomicrobiology to semi-industrial profiling of the microbiome. Our bioinformaticians are experts in the human microbiome at birth and in
Diversigen, Inc. and Alimentiv Inc. Announce Collaboration Agreement for Ulcerative Colitis Research Study
ST. PAUL, MN, June 25, 2020 – Diversigen, Inc., a subsidiary of OraSure Technologies Inc. (NASDAQ:OSUR), and Alimentiv Inc. (formerly Robarts Clinical Trials) today announced they have signed a collaboration agreement for a research study on patients with Acute Severe Ulcerative Colitis (ASUC). The study, titled: “Pharmacokinetics of Infliximab and
Diversigen Inc. Selected by Nom NomTM as the Preferred Provider for Metagenomics and Microbiome Sequencing and Analysis Services
PAUL, MN and OAKLAND, CA, May 22, 2020 – Diversigen, Inc., a subsidiary of OraSure Technologies Inc. (NASDAQ:OSUR), and Nom NomTM, a direct-to-consumer pet health brand, today announced that Nom Nom has selected Diversigen as their preferred provider for metagenomics and microbiome sequencing and analysis services. Diversigen will also serve
OraSure Technologies, Inc. Consolidates Microbiome Services Subsidiaries
OraSure Technologies, Inc. announces that its Diversigen and CoreBiome subsidiaries have combined their microbiome service offerings under the Diversigen name. The rebrand highlights the combined companies’ unparalleled scientific bench strength, state-of-the-art laboratory, ability to translate data to insights and collective focus on quality and service. Investor Contact: Roberto Cuca Chief Financial
Validation of our viral metagenomics sequencing and analysis pipeline for SARS-CoV-2 detection
In this article we’re sharing results from the validation study scientists at Diversigen and DNA Genotek undertook to ensure Diversigen’s viral metagenomics capabilities could be leveraged to help during the COVID-19 pandemic. When I was a boy and I would see scary things in the news, my mother would say
OraSure Technologies, Inc. Announces Purchase of Diversigen
Acquisition extends OraSure’s leadership position in the microbiome services industry BETHLEHEM, Pa., Nov. 06, 2019 (GLOBE NEWSWIRE) — OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point of care diagnostic tests and specimen collection and stabilization devices, today announced that it has entered into a definitive agreement to acquire the outstanding equity of Diversigen
DNa Genotek's Podcast & Blogs
Diversigen’s sister company DNA Genotek offers new insights on microbiome, DNA and RNA sample collection, stabilization and services, through their blogs and podcast.
The Microbiome Snapshot
DNA Genotek’s Microbiome Blog
Molecules, Microbes and Multiomics
DNA Genotek’s Podcast
Discover where our services can take you.
Diversigen provides services and generates data for research purposes only. Not all services are available in all regions.
